AbCellera Biologics Inc. (ABCL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:34PM EDT. Market open.
| Previous close | 4.0400 |
| Open | 4.0400 |
| Bid | 3.8100 x 100 |
| Ask | 3.8200 x 100 |
| Day's range | 3.7800 - 4.1990 |
| 52-week range | 3.6200 - 8.0500 |
| Volume | |
| Avg. volume | 1,412,967 |
| Market cap | 1.121B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5100 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.38 |
Insider MonkeyAbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript May 7, 2024 AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to AbCellera’s Q1, 2024 Business Update Conference Call. My name is Harry and […]
- Thomson Reuters StreetEvents
Q1 2024 Abcellera Biologics Inc Earnings Call
Q1 2024 Abcellera Biologics Inc Earnings Call
ZacksAbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
AbCellera Biologics (ABCL) delivered earnings and revenue surprises of 12.50% and 11.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.